Dasatinib (BMS-354825) in Subjects With Myeloid Blast Phase Chronic Myeloid Leukemia Resistant to or Intolerant of Imatinib Mesylate

Local Institution, Birmingham

Local Institution, Anaheim

Local Institution, Los Angeles

Local Institution, Stanford

Local Institution, Vallejo

Local Institution, Denver

Local Institution, Jacksonville

Local Institution, Tampa

Local Institution, Atlanta

Local Institution, Chicago

Local Institution, Kansas City

Local Institution, Baltimore

Local Institution, Boston

Local Institution, Detroit

Local Institution, St Louis

Local Institution, Hackensack

Local Institution, New Brunswick

Local Institution, New York

Local Institution, Portland

Local Institution, Pittsburgh

Local Institution, Nashville

Local Institution, Houston

Local Institution, Seattle

Local Institution, Adelaide

Local Institution, Vienna

Local Institution, B-Leuven

Local Institution, Edegem

Local Institution, Montreal

Local Institution, Aarhus

Local Institution, Helsinki

Local Institution, Lille

Local Institution, Lyon

Local Institution, Nantes

Local Institution, Paris

Local Institution, Pessac

Local Institution, Poitiers

Local Institution, Strasbourg

Local Institution, Hamburg

Local Institution, Mainz

Local Institution, Mannheim

Local Institution, Ramat Gan

Local Institution, Bologna

Local Institution, Napoli

Local Institution, Orbassano

Local Institution, Roma

Local Institution, Nijmegen

Local Institution, Rotterdam

Local Institution, Trondheim

Local Institution, Quezon City

Local Institution, Singapore

Local Institution, Jeollanam-Do

Local Institution, Kyunggi-Do

Local Institution, Seoul

Local Institution, Gothenburg

Local Institution, Lund

Local Institution, Umeå

Local Institution, Uppsala

Local Institution, Basel

Local Institution, Taipei

Local Institution, Taoyuan District

Local Institution, Glasgow

Local Institution, London